These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 34146057)
1. Magnetic resonance imaging in rhino-orbital-cerebral mucormycosis. Sreshta K; Dave TV; Varma DR; Nair AG; Bothra N; Naik MN; Sistla SK Indian J Ophthalmol; 2021 Jul; 69(7):1915-1927. PubMed ID: 34146057 [TBL] [Abstract][Full Text] [Related]
2. COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis. Bhattacharyya A; Sarma P; Kaur H; Kumar S; Bhattacharyya J; Prajapat M; Prakash A; Sharma S; Reddy DH; Thota P; Bansal S; Gautam BS; Medhi B Indian J Pharmacol; 2021; 53(6):499-510. PubMed ID: 34975140 [TBL] [Abstract][Full Text] [Related]
3. A retrospective analysis of eleven cases of invasive rhino-orbito-cerebral mucormycosis presented with orbital apex syndrome initially. Jiang N; Zhao G; Yang S; Lin J; Hu L; Che C; Wang Q; Xu Q BMC Ophthalmol; 2016 Jan; 16():10. PubMed ID: 26758904 [TBL] [Abstract][Full Text] [Related]
4. Transcutaneous retrobulbar injection of amphotericin B in rhino-orbital-cerebral mucormycosis: a review. Nair AG; Dave TV Orbit; 2022 Jun; 41(3):275-286. PubMed ID: 34720026 [TBL] [Abstract][Full Text] [Related]
5. Spectrum of intracranial complications of rhino-orbito-cerebral mucormycosis - resurgence in the era of COVID-19 pandemic: a pictorial essay. Kaushik KS; Ananthasivan R; Acharya UV; Rawat S; Patil UD; Shankar B; Jose A Emerg Radiol; 2021 Dec; 28(6):1097-1106. PubMed ID: 34605991 [TBL] [Abstract][Full Text] [Related]
6. Uncontrolled diabetes mellitus exacerbated by COVID-19-induced inflammation is the risk factor for COVID-19-associated rhino-orbito-cerebral mucormycosis: A matched pair case-control study. Karat S; Lobo AC; Satish D; Devaraj R; Manjooran RR; Nithyanandam S Indian J Ophthalmol; 2022 Aug; 70(8):3096-3101. PubMed ID: 35918980 [TBL] [Abstract][Full Text] [Related]
7. A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India. Vasanthapuram VH; Gupta R; Adulkar N; Nair AG; Bradoo RA; Hegde R; Singh U; Tadepalli S; Mukherjee B; Kamal S; Alam MS; Rao R; Ananthakrishna S; Backiavathy V; Murthy AK; D'Cunha L; Dudeja G; Joji A; Kiran A; Koka K; Goswami Mukhopadhyay M; Nisar SP; Rao PR; Shinde CA Orbit; 2023 Feb; 42(1):30-41. PubMed ID: 35192435 [TBL] [Abstract][Full Text] [Related]
9. Early Differential Diagnosis of Rhino-Orbito-Cerebral Mucormycosis and Bacterial Orbital Cellulitis: Based on Computed Tomography Findings. Son JH; Lim HB; Lee SH; Yang JW; Lee SB PLoS One; 2016; 11(8):e0160897. PubMed ID: 27501044 [TBL] [Abstract][Full Text] [Related]
10. Imaging Spectrum of Coronavirus Disease- 2019 Associated Rhino-Orbital-Cerebral Mucormycosis; From Sinonasal Inflammation to Intracranial Involvement. Khademi B; Dehghan A; Zia Z; Dehghan Y Acad Radiol; 2023 Sep; 30(9):1904-1914. PubMed ID: 36581530 [TBL] [Abstract][Full Text] [Related]
11. Orbital magnetic resonance imaging profile and clinicoradiological correlation in COVID-19-associated rhino-orbital-cerebral mucormycosis: A single-center study of 270 patients from North India. Hada M; Gupta P; Bagarhatta M; Tripathy K; Harsh A; Khilnani K; Mendiratta K; Agarwal S; Chouhan JK; Bhandari S Indian J Ophthalmol; 2022 Feb; 70(2):641-648. PubMed ID: 35086254 [TBL] [Abstract][Full Text] [Related]
12. Surgical & medical management of ROCM (Rhino-orbito-cerebral mucormycosis) epidemic in COVID-19 era and its outcomes - a tertiary care center experience. Soni K; Das A; Sharma V; Goyal A; Choudhury B; Chugh A; Kumar D; Yadav T; Jain V; Agarwal A; Garg M; Bhatnagar K; Elhence P; Bhatia PK; Garg MK; Misra S J Mycol Med; 2022 May; 32(2):101238. PubMed ID: 34979299 [TBL] [Abstract][Full Text] [Related]
13. Outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) as an adjuvant therapy for rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19. Shakrawal J; Sharma V; Goyal A; Kumar D; Meena S; Tiwari S; Jain V; Elhence P; Soni K; Choudhury B; Bhatnagar K; Garg MK; Misra S Int Ophthalmol; 2023 Jun; 43(6):1919-1926. PubMed ID: 36427099 [TBL] [Abstract][Full Text] [Related]
15. Posaconazole: an emerging therapeutic option for invasive rhino-orbito-cerebral mucormycosis. Manesh A; John AO; Mathew B; Varghese L; Rupa V; Zachariah A; Varghese GM Mycoses; 2016 Dec; 59(12):765-772. PubMed ID: 27443253 [TBL] [Abstract][Full Text] [Related]
16. CT and MRI Findings of Invasive Mucormycosis in the Setting of COVID-19: Experience From a Single Center in India. Joshi AR; Muthe MM; Patankar SH; Athawale A; Achhapalia Y AJR Am J Roentgenol; 2021 Dec; 217(6):1431-1432. PubMed ID: 34161127 [TBL] [Abstract][Full Text] [Related]
17. Spectrum of magnetic resonance imaging findings in post-COVID-19 patients presenting with rhino-orbito-cerebral mucormycosis in a teaching hospital in Malwa region of Punjab. Singh P; Kaur K; Jindal V; Kaur M; Kaur M; Singh N J Family Med Prim Care; 2022 Dec; 11(12):7788-7794. PubMed ID: 36994047 [TBL] [Abstract][Full Text] [Related]
18. Rhino-orbito-cerebral mucormycosis and its resurgence during COVID-19 pandemic: A review. Karkhur S; Soni D; Chauhan K; Sarkar D; Gautam M; Verma S; Nyodu R; Yadav N; Sharma B Indian J Ophthalmol; 2023 Jan; 71(1):39-56. PubMed ID: 36588206 [TBL] [Abstract][Full Text] [Related]
19. Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review. Bhattacharyya A; Sarma P; Sharma DJ; Das KK; Kaur H; Prajapat M; Kumar S; Bansal S; Prakash A; Avti P; Thota P; Reddy DH; Gautam BS; Medhi B Indian J Pharmacol; 2021; 53(4):317-327. PubMed ID: 34414911 [TBL] [Abstract][Full Text] [Related]
20. Fatal strokes in patients with rhino-orbito-cerebral mucormycosis and associated vasculopathy. Thajeb P; Thajeb T; Dai D Scand J Infect Dis; 2004; 36(9):643-8. PubMed ID: 15370650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]